Rhox2 inhibitors are a class of chemical compounds specifically designed to target and modulate the activity of the Rhox2 protein, a member of the reproductive homeobox (Rhox) gene cluster. Rhox2 is involved in the regulation of gene expression, particularly in reproductive tissues, where it plays a crucial role in processes such as spermatogenesis, embryonic development, and the function of reproductive organs. As a transcription factor, Rhox2 binds to DNA and influences the expression of various genes that are essential for reproductive biology. Inhibitors of Rhox2 are developed to interfere with its ability to bind to DNA or to disrupt its interactions with other proteins that are involved in transcriptional regulation. This interference allows researchers to explore the specific functions of Rhox2 in gene regulation and reproductive biology.
The development of Rhox2 inhibitors involves a detailed understanding of the protein's structure, particularly its DNA-binding domain and other regions critical for its function as a transcription factor. Structural biology techniques such as X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy are employed to determine the three-dimensional configuration of Rhox2, providing insights into its interaction with DNA and other transcriptional machinery. This structural information is crucial for identifying potential binding sites for inhibitors that can effectively block Rhox2's activity. Computational methods, including molecular docking and virtual screening, are used to identify small molecules that can specifically bind to these sites with high affinity. Once potential inhibitors are identified, they are synthesized and tested in vitro to evaluate their binding properties, specificity, and inhibitory potency. Through iterative cycles of chemical refinement and testing, these inhibitors are optimized to enhance their effectiveness and selectivity. The study of Rhox2 inhibitors not only sheds light on the role of this transcription factor in reproductive processes but also contributes to a broader understanding of the mechanisms of gene regulation in reproductive tissues and the complex interplay between transcription factors and gene expression.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Tamoxifen | 10540-29-1 | sc-208414 | 2.5 g | $272.00 | 18 | |
Blocks estrogen receptor, potentially altering hormone signaling pathways that Rhox2 might be involved in or regulated by. | ||||||
Flutamide | 13311-84-7 | sc-204757 sc-204757A sc-204757D sc-204757B sc-204757C | 1 g 5 g 25 g 500 g 1 kg | $47.00 $156.00 $171.00 $525.00 $941.00 | 4 | |
An androgen receptor antagonist, could affect androgen signaling pathways potentially linked to Rhox2's function. | ||||||
Letrozole | 112809-51-5 | sc-204791 sc-204791A | 25 mg 50 mg | $87.00 $147.00 | 5 | |
Inhibits aromatase, reducing estrogen synthesis and possibly affecting pathways regulated by Rhox2. | ||||||
Bicalutamide | 90357-06-5 | sc-202976 sc-202976A | 100 mg 500 mg | $42.00 $146.00 | 27 | |
An androgen receptor antagonist, potentially modulating androgen-dependent signaling pathways associated with Rhox2. | ||||||
MDV3100 | 915087-33-1 | sc-364354 sc-364354A | 5 mg 50 mg | $245.00 $1051.00 | 7 | |
An androgen receptor antagonist with a higher affinity than flutamide or bicalutamide, potentially affecting Rhox2-related pathways. | ||||||
ICI 182,780 | 129453-61-8 | sc-203435 sc-203435A | 1 mg 10 mg | $83.00 $187.00 | 34 | |
Degrades estrogen receptor, potentially altering estrogen-dependent signaling pathways that Rhox2 could be part of. | ||||||
Ketoconazole | 65277-42-1 | sc-200496 sc-200496A | 50 mg 500 mg | $63.00 $265.00 | 21 | |
Inhibits steroid synthesis, could indirectly affect hormone signaling pathways relevant to Rhox2's function. | ||||||
Anastrozole | 120511-73-1 | sc-217647 | 10 mg | $92.00 | 1 | |
Aromatase inhibitor, reduces estrogen synthesis, potentially impacting signaling pathways regulated by Rhox2. | ||||||
Exemestane | 107868-30-4 | sc-203045 sc-203045A | 25 mg 100 mg | $134.00 $411.00 | ||
Steroidal aromatase inhibitor, reduces estrogen levels, potentially affecting Rhox2-regulated pathways. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR, affecting cell growth and proliferation, which could be linked to the regulatory functions of Rhox2. | ||||||